rs10994336

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000373827.6(ANK3):​c.97-140415G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0797 in 152,064 control chromosomes in the GnomAD database, including 910 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.080 ( 910 hom., cov: 32)

Consequence

ANK3
ENST00000373827.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.705

Publications

106 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.211 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_001204404.2 linkc.64-140415G>A intron_variant Intron 1 of 43 NP_001191333.1
ANK3NM_001204403.2 linkc.97-140415G>A intron_variant Intron 2 of 43 NP_001191332.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000373827.6 linkc.97-140415G>A intron_variant Intron 2 of 43 1 ENSP00000362933.2
ANK3ENST00000503366.6 linkc.64-140415G>A intron_variant Intron 1 of 43 2 ENSP00000425236.1
ANK3ENST00000622427.4 linkn.64-140415G>A intron_variant Intron 1 of 32 2 ENSP00000483244.1

Frequencies

GnomAD3 genomes
AF:
0.0796
AC:
12101
AN:
151946
Hom.:
903
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0153
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.196
Gnomad ASJ
AF:
0.0447
Gnomad EAS
AF:
0.223
Gnomad SAS
AF:
0.144
Gnomad FIN
AF:
0.189
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0638
Gnomad OTH
AF:
0.0699
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0797
AC:
12114
AN:
152064
Hom.:
910
Cov.:
32
AF XY:
0.0895
AC XY:
6652
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.0153
AC:
635
AN:
41538
American (AMR)
AF:
0.197
AC:
3011
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.0447
AC:
155
AN:
3470
East Asian (EAS)
AF:
0.221
AC:
1142
AN:
5156
South Asian (SAS)
AF:
0.142
AC:
683
AN:
4818
European-Finnish (FIN)
AF:
0.189
AC:
1991
AN:
10560
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0638
AC:
4334
AN:
67954
Other (OTH)
AF:
0.0720
AC:
152
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
524
1049
1573
2098
2622
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0718
Hom.:
2575
Bravo
AF:
0.0795
Asia WGS
AF:
0.194
AC:
672
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
6.2
DANN
Benign
0.67
PhyloP100
0.70
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10994336; hg19: chr10-62179812; API